Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000902664-25-003076
Filing Date
2025-07-21
Accepted
2025-07-21 16:15:10
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 11964
2 JOINT FILING AGREEMENT p25-1537exhibit99_1.htm EX-99.1 2622
  Complete submission text file 0000902664-25-003076.txt   16348
Mailing Address 9 WEST 57TH STREET 29TH FLOOR NEW YORK NY 10019
Business Address 9 WEST 57TH STREET 29TH FLOOR NEW YORK NY 10019 212-446-4000
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP (Filed by) CIK: 0001595082 (see all company filings)

EIN.: 133863161 | State of Incorp.: DE
Type: SCHEDULE 13G

Mailing Address 45 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 45 SIDNEY STREET CAMBRIDGE MA 02139 617-374-7580
Blueprint Medicines Corp (Subject) CIK: 0001597264 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-88827 | Film No.: 251137443
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)